Mumbai : Gaudium IVF And Women Health Limited (Gaudium, The Company) is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years, has filed its Draft Red Herring Prospectus with SEBI in preparation for the IPO, the issue size will be of up to 2,08,86,100 equity shares with a face value of ₹5 each, out of which up to 1,83,54,400 equity shares will be issued as a Fresh Issue & up to 25,31,700 equity shares will be offered for sale.
Gaudium`s objective is to raise funds for funding capital expenditure towards the establishment of new IVF centers and funding working capital requirements for the establishment of new IVF centers. Additionally, it seeks to invest in its wholly owned subsidiary, EKK Global Private Limited (EKK Global), for launching FMCG products and funding its working capital requirements and general corporate purposes.
For the period ended 31st March 2024, The Company reported Revenue from operations of ₹ 5,348.46 Lakhs and EBITDA of ₹ 2,582.19 Lakhs & PAT of ₹ 1,660.12 Lakhs.
For the period ended 30th September 2024, The Company reported Revenue from operations of ₹ 3,169.12 Lakhs and EBITDA of ₹ 1,259.03 Lakhs & PAT of ₹ 814.41 Lakhs.